Myeloperoxidase is not useful for the early assessment of patients with chest pain.

@article{Eggers2010MyeloperoxidaseIN,
  title={Myeloperoxidase is not useful for the early assessment of patients with chest pain.},
  author={Kai Marten Eggers and Mikael Dellborg and Nina Johnston and Jonas Oldgren and Eva E Swahn and Per Venge and Bertil Lindahl},
  journal={Clinical biochemistry},
  year={2010},
  volume={43 3},
  pages={240-5}
}
BACKGROUND Myeloperoxidase (MPO) has been listed as a potentially useful risk marker in acute coronary syndrome. However, its clinical utility in patients with acute chest pain is not yet defined. DESIGN AND METHODS MPO (Architect, Abbott Diagnostics) was measured in 120 healthy controls and 303 chest pain patients who had been admitted to the coronary care units of three Swedish hospitals. RESULTS Chest pain patents had significantly higher median MPO levels compared to healthy controls… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…